Controlled Ovarian Stimulation Therapeutics
1. Cetrotide patent expiration
Treatment: Prevention of premature lh surges in women undergoing controlled ovarian stimulation
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6319192 | EMD SERONO INC | Method for the treatment of fertility disorders |
Apr, 2019
(6 years ago) | |
| US6863891 | EMD SERONO INC | Oligopeptide lyophilisate, their preparation and use |
Feb, 2014
(11 years ago) | |
| US7605121 | EMD SERONO INC | Oligopeptide lyophilisate, their preparation and use |
Feb, 2014
(11 years ago) | |
Drugs and Companies using CETRORELIX ACETATE ingredient
Market Authorisation Date: 11 August, 2000
Dosage: POWDER
More Information on Dosage
CETROTIDE family patents
